{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:56:55Z","timestamp":1788217015953,"version":"build-2803163510"},"reference-count":91,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH NIDDK SBIR Grant","award":["1R43DK122846-01"],"award-info":[{"award-number":["1R43DK122846-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Neurological disorders and type 2 diabetes mellitus (T2DM) are deeply intertwined. For example, autonomic neuropathy contributes to the development of T2DM and continued unmanaged T2DM causes further progression of nerve damage. Increasing glycemic control has been shown to prevent the onset and progression of diabetic autonomic neuropathies. Neuromodulation consisting of combined stimulation of celiac vagal fibers innervating the pancreas with concurrent electrical blockade of neuronal hepatic vagal fibers innervating the liver has been shown to increase glycemic control in animal models of T2DM. The present study demonstrated that the neuromodulation reversed glucose intolerance in alloxan-treated swine in both pre- and overt stages of T2DM. This was demonstrated by improved performance on oral glucose tolerance tests (OGTTs), as assessed by area under the curve (AUC). In prediabetic swine (fasting plasma glucose (FPG) range: 101\u2013119 mg\/dL) the median AUC decreased from 31.9 AUs (IQR = 28.6, 35.5) to 15.9 AUs (IQR = 15.1, 18.3) p = 0.004. In diabetic swine (FPG range: 133\u2013207 mg\/dL) the median AUC decreased from 54.2 AUs (IQR = 41.5, 56.6) to 16.0 AUs (IQR = 15.4, 21.5) p = 0.003. This neuromodulation technique may offer a new treatment for T2DM and reverse glycemic dysregulation at multiple states of T2DM involved in diabetic neuropathy including at its development and during progression.<\/jats:p>","DOI":"10.3390\/biomedicines11092452","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T10:14:11Z","timestamp":1693822451000},"page":"2452","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Combining Celiac and Hepatic Vagus Nerve Neuromodulation Reverses Glucose Intolerance and Improves Glycemic Control in Pre- and Overt-Type 2 Diabetes Mellitus"],"prefix":"10.3390","volume":"11","author":[{"given":"Jonathan J.","family":"Waataja","sequence":"first","affiliation":[{"name":"ReShape Lifesciences Inc., Irvine, CA 92618, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders J.","family":"Asp","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN 55605, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Billington","sequence":"additional","affiliation":[{"name":"Minnesota Veterans\u2019 Administration Medical Center, Minneapolis, MN 55417, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.2337\/diacare.26.11.3035","article-title":"Influence of autonomic nervous system dysfunction on the development of type 2 diabetes: The CARDIA study","volume":"26","author":"Carnethon","year":"2003","journal-title":"Diabetes Care"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1161\/01.CIR.0000066324.74807.95","article-title":"Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: The Atherosclerosis Risk In Communities study, 1987\u20131998","volume":"107","author":"Carnethon","year":"2003","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e3175","DOI":"10.1002\/dmrr.3175","article-title":"Decreased heart rate variability as a predictor for diabetes-A prospective study of the Brazilian longitudinal study of adult health","volume":"35","author":"Hoshi","year":"2019","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2337\/dc19-1384","article-title":"Decreased Vagal Activity and Deviation in Sympathetic Activity Precedes Development of Diabetes","volume":"43","author":"Lee","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0168-8227(95)01190-0","article-title":"Association of vagal tone with serum insulin, glucose, and diabetes mellitus--The ARIC Study","volume":"30","author":"Liao","year":"1995","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_6","first-page":"e19142","article-title":"A Comprehensive Review of Neuronal Changes in Diabetics","volume":"13","author":"Luna","year":"2021","journal-title":"Cureus"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0002-9149(00)00920-6","article-title":"Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study)","volume":"86","author":"Singh","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1111\/jdi.13691","article-title":"Autonomic dysfunction, diabetes and metabolic syndrome","volume":"12","author":"Yu","year":"2021","journal-title":"J. Diabetes Investig."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2337\/dc19-2367","article-title":"Both Prediabetes and Type 2 Diabetes Are Associated With Lower Heart Rate Variability: The Maastricht Study","volume":"43","author":"Coopmans","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2337\/diacare.28.3.668","article-title":"Diabetes, glucose, insulin, and heart rate variability: The Atherosclerosis Risk in Communities (ARIC) study","volume":"28","author":"Schroeder","year":"2005","journal-title":"Diabetes Care"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40101-021-00272-y","article-title":"Assessment of autonomic function by long-term heart rate variability: Beyond the classical framework of LF and HF measurements","volume":"40","author":"Hayano","year":"2021","journal-title":"J. Physiol. Anthropol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Poon, A.K., Whitsel, E.A., Heiss, G., Soliman, E.Z., Wagenknecht, L.E., Suzuki, T., and Loehr, L. (2020). Insulin resistance and reduced cardiac autonomic function in older adults: The Atherosclerosis Risk in Communities study. BMC Cardiovasc. Disord., 20.","DOI":"10.1186\/s12872-020-01496-z"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12933-016-0411-8","article-title":"Alterations in heart rate variability during everyday life are linked to insulin resistance. A role of dominating sympathetic over parasympathetic nerve activity?","volume":"15","author":"Svensson","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2188\/jea.JE20140254","article-title":"Heart Rate Variability, Insulin Resistance, and Insulin Sensitivity in Japanese Adults: The Toon Health Study","volume":"25","author":"Saito","year":"2015","journal-title":"J. Epidemiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12933-016-0364-y","article-title":"Association of glucose homeostasis measures with heart rate variability among Hispanic\/Latino adults without diabetes: The Hispanic Community Health Study\/Study of Latinos (HCHS\/SOL)","volume":"15","author":"Meyer","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ajhb.22475","article-title":"Associations between insulin and heart rate variability in police officers","volume":"26","author":"Charles","year":"2014","journal-title":"Am. J. Hum. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.106.634949","article-title":"Diabetic cardiovascular autonomic neuropathy","volume":"115","author":"Vinik","year":"2007","journal-title":"Circulation"},{"key":"ref_18","first-page":"224","article-title":"Cardiac autonomic dysfunctions in type 2 diabetes mellitus: An investigative study with heart rate variability measures","volume":"12","author":"John","year":"2022","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Smith, S., Normahani, P., Lane, T., Hohenschurz-Schmidt, D., Oliver, N., and Davies, A.H. (2022). Prevention and Management Strategies for Diabetic Neuropathy. Life, 12.","DOI":"10.3390\/life12081185"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"790255","DOI":"10.3389\/fendo.2022.790255","article-title":"Neurodegeneration of the cornea and retina in patients with type 1 diabetes without clinical evidence of diabetic retinopathy","volume":"13","author":"Carmichael","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ncpneuro0124","article-title":"Therapy Insight: Type 2 diabetes mellitus and the risk of late-onset Alzheimer\u2019s disease","volume":"2","author":"Haan","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jdi.12042","article-title":"Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease","volume":"4","author":"Vinik","year":"2013","journal-title":"J. Diabetes Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/CIRCULATIONAHA.108.837369","article-title":"Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications study (DCCT\/EDIC)","volume":"119","author":"Low","year":"2009","journal-title":"Circulation"},{"key":"ref_24","first-page":"161","article-title":"Adherence to healthy lifestyle behaviours in patients with type 2 diabetes in Spain","volume":"47","year":"2021","journal-title":"Semergen"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2042018821997320","DOI":"10.1177\/2042018821997320","article-title":"GLP-1 receptor agonists: An updated review of head-to-head clinical studies","volume":"12","author":"Trujillo","year":"2021","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1007\/s12325-022-02153-x","article-title":"Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review","volume":"39","author":"Jensterle","year":"2022","journal-title":"Adv. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2337\/ds16-0026","article-title":"Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes","volume":"30","author":"Hinnen","year":"2017","journal-title":"Diabetes Spectr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.2147\/PPA.S277676","article-title":"Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States","volume":"14","author":"Weiss","year":"2020","journal-title":"Patient Prefer. Adherence"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e002517","DOI":"10.1136\/bmjdrc-2021-002517","article-title":"Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK","volume":"10","author":"Weiss","year":"2022","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/DMSO.S141235","article-title":"Reasons for discontinuation of GLP1 receptor agonists: Data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes","volume":"10","author":"Sikirica","year":"2017","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.diabet.2019.01.006","article-title":"Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings","volume":"45","author":"Guerci","year":"2019","journal-title":"Diabetes Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s12325-014-0171-3","article-title":"Retrospective analysis of long-term adherence to and persistence with DPP-4 inhibitors in US adults with type 2 diabetes mellitus","volume":"31","author":"Farr","year":"2014","journal-title":"Adv. Ther."},{"key":"ref_33","first-page":"e6932","article-title":"Type 2 Diabetic Patients Adherence Towards Their Medications","volume":"12","author":"Alshehri","year":"2020","journal-title":"Cureus"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s13300-019-0615-5","article-title":"GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data","volume":"10","author":"Divino","year":"2019","journal-title":"Diabetes Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s12325-014-0166-0","article-title":"Retrospective study of adherence to glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes mellitus in the United States","volume":"31","author":"Johnston","year":"2014","journal-title":"Adv. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s13300-021-01053-7","article-title":"Semaglutide Once-Weekly Persistence and Adherence Versus Other GLP-1 RAs in Patients with Type 2 Diabetes in a US Real-World Setting","volume":"12","author":"Uzoigwe","year":"2021","journal-title":"Diabetes Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/1932296820928100","article-title":"Insulin Pump Therapy for Patients With Type 2 Diabetes Mellitus: Evidence, Current Barriers, and New Technologies","volume":"15","author":"Freckmann","year":"2021","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"McAdams, B.H., and Rizvi, A.A. (2016). An Overview of Insulin Pumps and Glucose Sensors for the Generalist. J. Clin. Med., 5.","DOI":"10.3390\/jcm5010005"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1080\/13102818.2019.1643783","article-title":"Advances and potential of gene therapy for type 2 diabetes mellitus","volume":"33","author":"Yue","year":"2019","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1038\/s41598-021-83361-3","article-title":"Optogenetic stimulation of cholinergic fibers for the modulation of insulin and glycemia","volume":"11","author":"Fontaine","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/jnc.15314","article-title":"Chemogenetic approaches to identify metabolically important GPCR signaling pathways: Therapeutic implications","volume":"158","author":"Meister","year":"2021","journal-title":"J. Neurochem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1089\/hum.2019.197","article-title":"Public Acceptability of Gene Therapy and Gene Editing for Human Use: A Systematic Review","volume":"31","author":"Delhove","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"109194","DOI":"10.1016\/j.diabres.2022.109194","article-title":"Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA-1 Study)","volume":"184","author":"Deviere","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"10542","DOI":"10.3748\/wjg.v21.i37.10542","article-title":"Endoscopic management of gastrointestinal perforations, leaks and fistulas","volume":"21","author":"Rogalski","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.soard.2009.05.013","article-title":"Intestinal electrical stimulation decreases postprandial blood glucose levels in rats","volume":"5","author":"Khawaled","year":"2009","journal-title":"Surg. Obes. Relat. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11695-015-1774-8","article-title":"Duodenal Electric Stimulation: Results of a First-in-Man Study","volume":"26","author":"Aberle","year":"2016","journal-title":"Obes. Surg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41551-022-00870-w","article-title":"Stimulation of the hepatoportal nerve plexus with focused ultrasound restores glucose homoeostasis in diabetic mice, rats and swine","volume":"6","author":"Cotero","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1109\/TBCAS.2019.2959439","article-title":"Flexible Body-Conformal Ultrasound Patches for Image-Guided Neuromodulation","volume":"14","author":"Pashaei","year":"2020","journal-title":"IEEE Trans. Biomed. Circuits. Syst."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"867563","DOI":"10.3389\/fnhum.2022.867563","article-title":"Transcutaneous Auricular Vagus Nerve Stimulation Differently Modifies Functional Brain Networks of Subjects With Different Epilepsy Types","volume":"16","author":"Rings","year":"2022","journal-title":"Front. Hum. Neurosci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fpsyt.2018.00020","article-title":"Treating Depression with Transcutaneous Auricular Vagus Nerve Stimulation: State of the Art and Future Perspectives","volume":"9","author":"Kong","year":"2018","journal-title":"Front. Psychiatry"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Li, S., Zhai, X., Rong, P., McCabe, M.F., Wang, X., Zhao, J., Ben, H., and Wang, S. (2014). Therapeutic effect of vagus nerve stimulation on depressive-like behavior, hyperglycemia and insulin receptor expression in Zucker fatty rats. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0112066"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e15253","DOI":"10.14814\/phy2.15253","article-title":"Transcutaneous auricular vagus nerve stimulation augments postprandial inhibition of ghrelin","volume":"10","author":"Kozorosky","year":"2022","journal-title":"Physiol. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Huang, F., Dong, J., Kong, J., Wang, H., Meng, H., Spaeth, R.B., Camhi, S., Liao, X., Li, X., and Zhai, X. (2014). Effect of transcutaneous auricular vagus nerve stimulation on impaired glucose tolerance: A pilot randomized study. BMC Complement. Altern. Med., 14.","DOI":"10.1186\/1472-6882-14-203"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"20466","DOI":"10.1038\/s41598-020-77430-2","article-title":"No modulation of postprandial metabolism by transcutaneous auricular vagus nerve stimulation: A cross-over study in 15 healthy men","volume":"10","author":"Vosseler","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e12718","DOI":"10.14814\/phy2.12718","article-title":"Contrasting effects of afferent and efferent vagal nerve stimulation on insulin secretion and blood glucose regulation","volume":"4","author":"Meyers","year":"2016","journal-title":"Physiol. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e13953","DOI":"10.14814\/phy2.13953","article-title":"Cervical vagal nerve stimulation impairs glucose tolerance and suppresses insulin release in conscious rats","volume":"6","author":"Stauss","year":"2018","journal-title":"Physiol. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e15257","DOI":"10.14814\/phy2.15257","article-title":"Blood glucose modulation and safety of efferent vagus nerve stimulation in a type 2 diabetic rat model","volume":"10","author":"Payne","year":"2022","journal-title":"Physiol. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s11695-019-03901-9","article-title":"Vagal Nerve Stimulation for Glycemic Control in a Rodent Model of Type 2 Diabetes","volume":"29","author":"Yin","year":"2019","journal-title":"Obes. Surg."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2337\/db18-1209","article-title":"Sympathetic Denervation of the Common Hepatic Artery Lessens Glucose Intolerance in the Fat- and Fructose-Fed Dog","volume":"68","author":"Kraft","year":"2019","journal-title":"Diabetes"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000487483","article-title":"Protective Role of the Hepatic Vagus Nerve against Liver Metastasis in Mice","volume":"24","author":"Hiramoto","year":"2018","journal-title":"Neuroimmunomodulation"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1152\/physiol.00069.2013","article-title":"Peripheral and central glucose sensing in hypoglycemic detection","volume":"29","author":"Donovan","year":"2014","journal-title":"Physiology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000065594","article-title":"The role of the autonomic nervous system in liver regeneration and apoptosis--recent developments","volume":"66","author":"Kiba","year":"2002","journal-title":"Digestion"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0031-9384(93)90147-8","article-title":"Modulation of insulin secretion by hepatic vagotomy in cirrhotic rats","volume":"53","author":"Okazaki","year":"1993","journal-title":"Physiol. Behav."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1005932","DOI":"10.3389\/fnins.2022.1005932","article-title":"Use of a bio-electronic device comprising of targeted dual neuromodulation of the hepatic and celiac vagal branches demonstrated enhanced glycemic control in a type 2 diabetic rat model as well as in an Alloxan treated swine model","volume":"16","author":"Waataja","year":"2022","journal-title":"Front. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"056013","DOI":"10.1088\/1741-2560\/8\/5\/056013","article-title":"Effects of high-frequency alternating current on axonal conduction through the vagus nerve","volume":"8","author":"Waataja","year":"2011","journal-title":"J. Neural. Eng."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Manell, E., Hedenqvist, P., Svensson, A., and Jensen-Waern, M. (2016). Establishment of a Refined Oral Glucose Tolerance Test in Pigs, and Assessment of Insulin, Glucagon and Glucagon-Like Peptide-1 Responses. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0148896"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Manell, E., Hedenqvist, P., and Jensen-Waern, M. (2021). Training Pigs for Oral Glucose Tolerance Test-Six Years\u2019 Experience of a Refined Model. Animals, 11.","DOI":"10.3390\/ani11061677"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003). Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 26, S5\u2013S20.","DOI":"10.2337\/diacare.26.2007.S5"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0165-1838(83)90039-5","article-title":"Evidence for a role of the gastric, coeliac and hepatic branches in vagally stimulated insulin secretion in the rat","volume":"7","author":"Berthoud","year":"1983","journal-title":"J. Auton. Nerv. Syst."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1210\/endo-117-1-307","article-title":"The hepatic vagus nerve and the neural regulation of insulin secretion","volume":"117","author":"Lee","year":"1985","journal-title":"Endocrinology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2337\/db07-1202","article-title":"Differential antidiabetic efficacy of incretin agonists versus DPP-4 inhibition in high fat fed mice","volume":"57","author":"Lamont","year":"2008","journal-title":"Diabetes"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Claudino, M., Ceolin, D.S., Alberti, S., Cestari, T.M., Spadella, C.T., Rubira-Bullen, I.R., Garlet, G.P., and de Assis, G.F. (2007). Alloxan-induced diabetes triggers the development of periodontal disease in rats. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0001320"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/01913123.2019.1710313","article-title":"Early ultra- and microstructural alterations in rat pancreas in alloxan-induced diabetes mellitus","volume":"44","author":"Titova","year":"2020","journal-title":"Ultrastruct. Pathol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.sjbs.2018.05.028","article-title":"Antidiabetic potential of Caralluma europaea against alloxan-induced diabetes in mice","volume":"26","author":"Dra","year":"2019","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4239\/wjd.v9.i12.239","article-title":"Pathological changes in the cellular structures of retina and choroidea in the early stages of alloxan-induced diabetes","volume":"9","author":"Danilova","year":"2018","journal-title":"World J. Diabetes"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"383","DOI":"10.5051\/jpis.2018.48.6.383","article-title":"Determination of the optimal diabetes duration for bone regeneration experiments in an alloxan-induced diabetic rabbit calvarial defect model","volume":"48","author":"Jeong","year":"2018","journal-title":"J. Periodontal. Implant. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12967-018-1431-9","article-title":"Alloxan-induced diabetes exacerbates coronary atherosclerosis and calcification in Ossabaw miniature swine with metabolic syndrome","volume":"16","author":"Badin","year":"2018","journal-title":"J. Transl. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e008807","DOI":"10.1161\/JAHA.118.008807","article-title":"Xanthine Oxidase Inhibitor Allopurinol Prevents Oxidative Stress-Mediated Atrial Remodeling in Alloxan-Induced Diabetes Mellitus Rabbits","volume":"7","author":"Yang","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_79","first-page":"1","article-title":"Vagal Nerve Block for Improvements in Glycemic Control in Obese Patients with Type 2 Diabetes Mellitus: Three-Year Results of the VBLOC DM2 Study","volume":"4","author":"Herrera","year":"2017","journal-title":"J. Diabetes Obes."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"18020","DOI":"10.1038\/s41598-022-22675-2","article-title":"Parasympathetic tonus in type 2 diabetes and pre-diabetes and its clinical implications","volume":"12","author":"Hadad","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Ali, M.K., and Chen, J.D.Z. (2023). Roles of Heart Rate Variability in Assessing Autonomic Nervous System in Functional Gastrointestinal Disorders: A Systematic Review. Diagnostics, 13.","DOI":"10.3390\/diagnostics13020293"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1081\/CEH-120019148","article-title":"Insulin resistant state in type 2 diabetes is related to advanced autonomic neuropathy","volume":"25","author":"Nakano","year":"2003","journal-title":"Clin. Exp. Hypertens."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12264-018-0304-9","article-title":"Decreased beta-Cell Function is Associated with Cardiovascular Autonomic Neuropathy in Chinese Patients Newly Diagnosed with Type 2 Diabetes","volume":"35","author":"Yang","year":"2019","journal-title":"Neurosci. Bull."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Picard, M., Tauveron, I., Magdasy, S., Benichou, T., Bagheri, R., Ugbolue, U.C., Navel, V., and Dutheil, F. (2021). Effect of exercise training on heart rate variability in type 2 diabetes mellitus patients: A systematic review and meta-analysis. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0251863"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cmet.2006.12.010","article-title":"An afferent vagal nerve pathway links hepatic PPARalpha activation to glucocorticoid-induced insulin resistance and hypertension","volume":"5","author":"Xiaozhong","year":"2007","journal-title":"Cell Metab."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4239\/wjd.v4.i4.114","article-title":"Genetics of type 2 diabetes","volume":"4","author":"Ali","year":"2013","journal-title":"World J. Diabetes"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Kolb, H., and Martin, S. (2017). Environmental\/lifestyle factors in the pathogenesis and prevention of type 2 diabetes. BMC Med., 15.","DOI":"10.1186\/s12916-017-0901-x"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.2337\/dc11-0447","article-title":"Obesity and type 2 diabetes: What can be unified and what needs to be individualized?","volume":"34","author":"Eckel","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2337\/dc16-1580","article-title":"Effects of Liraglutide on Heart Rate and Heart Rate Variability: A Randomized, Double-Blind, Placebo-Controlled Crossover Study","volume":"40","author":"Kumarathurai","year":"2017","journal-title":"Diabetes Care"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/bcpt.13422","article-title":"The counterregulatory response to hypoglycaemia in the pig","volume":"127","author":"Gradel","year":"2020","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11892-019-1212-8","article-title":"Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes","volume":"19","author":"Hicks","year":"2019","journal-title":"Curr. Diab. Rep."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/9\/2452\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:46:06Z","timestamp":1760129166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/9\/2452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":91,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["biomedicines11092452"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines11092452","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]}}}